Page last updated: 2024-08-21

dihydroergotamine and Sclerosis, Systemic

dihydroergotamine has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balda, BR; Hahne, T1

Other Studies

1 other study(ies) available for dihydroergotamine and Sclerosis, Systemic

ArticleYear
[Finger tip necroses after dihydroergotamine medication in limited systemic scleroderma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1998, Volume: 49, Issue:9

    Topics: Aged; Contraindications; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fingers; Humans; Migraine Disorders; Necrosis; Raynaud Disease; Risk Factors; Scleroderma, Systemic

1998